{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:21:39Z","timestamp":1791091299271,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Center of Innovation Program launched by the Japan Science and Technology Agency","award":["JPMJCE1302, JPMJCA2201, JPMJPF2210"],"award-info":[{"award-number":["JPMJCE1302, JPMJCA2201, JPMJPF2210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Equol, a gut microbiota\u2013derived metabolite of the soy isoflavone daidzein that acts mainly via estrogen receptor \u03b2, has been linked to several health benefits, including relief of menopausal symptoms and prevention of arteriosclerosis. However, little is known about how equol production capability changes over time and how these changes relate to the gut microbiota.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from 498 community-dwelling adults who participated annually in a health checkup between 2016 and 2019. Equol production was assessed each year using urinary equol and daidzein concentrations. Participants were classified as producers when log10(equol\/daidzein)\u2009&gt;\u2009\u2212\u20091.75 and were further categorized as stable producers (equol positive in all 4 years), unstable producers (equol positive in at least 1 but not all years), or non-producers (equol negative in all years). Gut microbiota profiles were obtained from fecal samples collected in 2016 and analyzed for bacterial diversity, composition, and predicted metabolic pathways. Dietary daidzein intake was estimated using a validated brief-type self-administered diet history questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 498 participants, 30.9% were stable producers, 26.1% unstable producers, and 43.0% non-producers. Stable producers showed significantly higher gut bacterial diversity than unstable producers and non-producers and a distinct microbiota composition, despite comparable daidzein intake across groups. At the genus level, differential abundance analysis indicated that taxa such as\n                      <jats:italic>Eubacterium coprostanoligenes<\/jats:italic>\n                      group,\n                      <jats:italic>Subdoligranulum<\/jats:italic>\n                      ,\n                      <jats:italic>Ruminococcus<\/jats:italic>\n                      ,\n                      <jats:italic>Alistipes<\/jats:italic>\n                      , and\n                      <jats:italic>Coprococcus<\/jats:italic>\n                      were enriched in stable producers, whereas\n                      <jats:italic>Ruminococcus gnavus<\/jats:italic>\n                      group,\n                      <jats:italic>Fusobacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Eggerthella<\/jats:italic>\n                      ,\n                      <jats:italic>Flavonifractor<\/jats:italic>\n                      , and\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      were more abundant in non-producers. Several genera enriched in stable producers are known short-chain fatty acid producers, whereas some genera enriched in non-producers have been reported in the context of intestinal dysbiosis and inflammation. Functional prediction analysis further indicated that stable producers had microbiota with enhanced pathways related to vitamin B and menaquinone biosynthesis, sulfate degradation, and methanogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The stability of equol production capability over time is associated with higher gut microbiota diversity and specific compositional and functional features. A gut microbiota composition favoring saccharolytic and butyrogenic bacteria may support sustained equol production, whereas a microbiota dominated by potentially pro-inflammatory taxa may be less conducive to equol production.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-04749-7","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:36:20Z","timestamp":1769423780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stability of equol production capability is associated with the diversity of the gut microbiota of the host: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0962-1159","authenticated-orcid":false,"given":"Kaori","family":"Iino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Iino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mako","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Tanabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Murashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"12","key":"4749_CR1","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1093\/jn\/132.12.3577","volume":"132","author":"KD Setchell","year":"2002","unstructured":"Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132(12):3577\u201384.","journal-title":"J Nutr"},{"issue":"21","key":"4749_CR2","doi-asserted-by":"publisher","first-page":"17808","DOI":"10.1074\/jbc.M100953200","volume":"276","author":"J An","year":"2001","unstructured":"An J, et al. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem. 2001;276(21):17808\u201314.","journal-title":"J Biol Chem"},{"issue":"1","key":"4749_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/metabo5010056","volume":"5","author":"F Rafii","year":"2015","unstructured":"Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone Daidzin to equol. Metabolites. 2015;5(1):56\u201373.","journal-title":"Metabolites"},{"issue":"4","key":"4749_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1042\/bj0261227","volume":"26","author":"GF Marrian","year":"1932","unstructured":"Marrian GF, Haslewood GAD. Equol, a new inactive phenol isolated from the Ketohydroxyoestrin fraction of mares\u2019 urine. Biochem J. 1932;26(4):1227\u201332.","journal-title":"Biochem J"},{"issue":"1","key":"4749_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1677\/joe.0.1020049","volume":"102","author":"M Axelson","year":"1984","unstructured":"Axelson M, et al. Soya\u2013a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol. 1984;102(1):49\u201356.","journal-title":"J Endocrinol"},{"issue":"2","key":"4749_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0014-5793(81)80322-5","volume":"123","author":"M Axelson","year":"1981","unstructured":"Axelson M, Setchell KDR. The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 1981;123(2):337\u201342.","journal-title":"FEBS Lett"},{"issue":"5","key":"4749_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/ajcn\/81.5.1072","volume":"81","author":"KD Setchell","year":"2005","unstructured":"Setchell KD, et al. S-equol, a potent ligand for Estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005;81(5):1072\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"4749_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/jwh.2011.2753","volume":"21","author":"T Aso","year":"2012","unstructured":"Aso T, et al. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. J Womens Health (Larchmt). 2012;21(1):92\u2013100.","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"4749_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/jmf.2018.4265","volume":"22","author":"JW Daily","year":"2019","unstructured":"Daily JW, et al. Equol decreases hot flashes in postmenopausal women: A systematic review and Meta-Analysis of randomized clinical trials. J Med Food. 2019;22(2):127\u201339.","journal-title":"J Med Food"},{"issue":"6","key":"4749_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/jwh.2011.3153","volume":"21","author":"BH Jenks","year":"2012","unstructured":"Jenks BH, et al. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency. J Womens Health (Larchmt). 2012;21(6):674\u201382.","journal-title":"J Womens Health (Larchmt)"},{"issue":"8","key":"4749_CR11","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1039\/C6FO00223D","volume":"7","author":"TH Liu","year":"2016","unstructured":"Liu TH, Tsai TY. Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats. Food Funct. 2016;7(8):3444\u201357.","journal-title":"Food Funct"},{"issue":"2","key":"4749_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jjco\/hyh015","volume":"34","author":"H Akaza","year":"2004","unstructured":"Akaza H, et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004;34(2):86\u20139.","journal-title":"Jpn J Clin Oncol"},{"key":"4749_CR13","doi-asserted-by":"crossref","unstructured":"Liu F, et al. Association of urinary phytoestrogens with hormone-related cancers and cancer biomarkers: NHANES 1999\u20132010. Br J Nutr. 2023;130:1\u201315.","DOI":"10.1017\/S0007114522003877"},{"key":"4749_CR14","doi-asserted-by":"crossref","unstructured":"Sekikawa A, et al. Potential protective mechanisms of S-equol, a metabolite of soy isoflavone by the gut Microbiome, on cognitive decline and dementia. Int J Mol Sci. 2022;23(19):11463.","DOI":"10.3390\/ijms231911921"},{"issue":"3","key":"4749_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3945\/ajcn.115.125690","volume":"103","author":"S Hazim","year":"2016","unstructured":"Hazim S, et al. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr. 2016;103(3):694\u2013702.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"4749_CR16","doi-asserted-by":"publisher","first-page":"155798832211155","DOI":"10.1177\/15579883221115598","volume":"16","author":"C Iino","year":"2022","unstructured":"Iino C, et al. Reduced equol production and gut microbiota features in men with lean nonalcoholic fatty liver disease. Am J Mens Health. 2022;16(4):15579883221115598.","journal-title":"Am J Mens Health"},{"key":"4749_CR17","doi-asserted-by":"crossref","unstructured":"Iino C et al. Daidzein intake is associated with equol producing status through an increase in the intestinal bacteria responsible for equol production. Nutrients. 2019;11(2).","DOI":"10.3390\/nu11020433"},{"issue":"12","key":"4749_CR18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/nu8120754","volume":"8","author":"M Messina","year":"2016","unstructured":"Messina M. Soy and health update: evaluation of the clinical and epidemiologic literature. Nutrients. 2016;8(12):754.","journal-title":"Nutrients"},{"issue":"12","key":"4749_CR19","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3945\/jn.113.179564","volume":"143","author":"KD Setchell","year":"2013","unstructured":"Setchell KD, et al. Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults. J Nutr. 2013;143(12):1950\u20138.","journal-title":"J Nutr"},{"issue":"6","key":"4749_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1079\/BJN20051565","volume":"94","author":"CL Frankenfeld","year":"2005","unstructured":"Frankenfeld CL, et al. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr. 2005;94(6):873\u20136.","journal-title":"Br J Nutr"},{"issue":"8","key":"4749_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1017\/S0007114511004223","volume":"107","author":"AA Franke","year":"2012","unstructured":"Franke AA, et al. Equol production changes over time in pre-menopausal women. Br J Nutr. 2012;107(8):1201\u20136.","journal-title":"Br J Nutr"},{"issue":"7","key":"4749_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1017\/S1368980011000504","volume":"14","author":"S Kobayashi","year":"2011","unstructured":"Kobayashi S, et al. Comparison of relative validity of food group intakes estimated by comprehensive and brief-type self-administered diet history questionnaires against 16 d dietary records in Japanese adults. Public Health Nutr. 2011;14(7):1200\u201311.","journal-title":"Public Health Nutr"},{"issue":"8","key":"4749_CR23","doi-asserted-by":"publisher","first-page":"e105592","DOI":"10.1371\/journal.pone.0105592","volume":"9","author":"S Takahashi","year":"2014","unstructured":"Takahashi S, et al. Development of a prokaryotic universal primer for simultaneous analysis of bacteria and archaea using next-generation sequencing. PLoS ONE. 2014;9(8):e105592.","journal-title":"PLoS ONE"},{"issue":"7","key":"4749_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00203-015-1125-0","volume":"197","author":"T Hisada","year":"2015","unstructured":"Hisada T, Endoh K, Kuriki K. Inter- and intra-individual variations in seasonal and daily stabilities of the human gut microbiota in Japanese. Arch Microbiol. 2015;197(7):919\u201334.","journal-title":"Arch Microbiol"},{"issue":"8","key":"4749_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"Database issue","key":"4749_CR26","first-page":"D590","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4749_CR27","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick H, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"4749_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"key":"4749_CR29","doi-asserted-by":"crossref","unstructured":"Yang C et al. ggpicrust2: an R package for PICRUSt2 predicted functional profile analysis and visualization. Bioinformatics. 2023;39(8).","DOI":"10.1093\/bioinformatics\/btad470"},{"key":"4749_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2023. Available from: https:\/\/www.R-project.org\/."},{"issue":"2","key":"4749_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-020-05957-z","volume":"185","author":"M Hatono","year":"2021","unstructured":"Hatono M, et al. Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments. Breast Cancer Res Treat. 2021;185(2):307\u201316.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4749_CR32","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1095\/biolreprod.103.023713","volume":"70","author":"TD Lund","year":"2004","unstructured":"Lund TD, et al. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod. 2004;70(4):1188\u201395.","journal-title":"Biol Reprod"},{"issue":"2","key":"4749_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1573403X15666181205104717","volume":"15","author":"A Sekikawa","year":"2019","unstructured":"Sekikawa A, et al. Effect of S-equol and soy isoflavones on heart and brain. Curr Cardiol Rev. 2019;15(2):114\u201335.","journal-title":"Curr Cardiol Rev"},{"issue":"10","key":"4749_CR34","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1136\/gutjnl-2016-313678","volume":"66","author":"F Sommer","year":"2017","unstructured":"Sommer F, et al. Microbiomarkers in inflammatory bowel diseases: caveats come with caviar. Gut. 2017;66(10):1734\u20138.","journal-title":"Gut"},{"issue":"2","key":"4749_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C Manichanh","year":"2006","unstructured":"Manichanh C, et al. Reduced diversity of faecal microbiota in crohn\u2019s disease revealed by a metagenomic approach. Gut. 2006;55(2):205\u201311.","journal-title":"Gut"},{"key":"4749_CR36","doi-asserted-by":"publisher","first-page":"k2179","DOI":"10.1136\/bmj.k2179","volume":"361","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, et al. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179.","journal-title":"BMJ"},{"issue":"7","key":"4749_CR37","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1017\/S0007114516003068","volume":"116","author":"T Takagi","year":"2016","unstructured":"Takagi T, et al. Partially hydrolysed Guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA. Br J Nutr. 2016;116(7):1199\u2013205.","journal-title":"Br J Nutr"},{"issue":"6","key":"4749_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/CS20200128","volume":"134","author":"XF Chen","year":"2020","unstructured":"Chen XF, Chen X, Tang X. Short-chain fatty acid, acylation and cardiovascular diseases. Clin Sci (Lond). 2020;134(6):657\u201376.","journal-title":"Clin Sci (Lond)"},{"issue":"Pt 7","key":"4749_CR39","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1099\/ijs.0.007674-0","volume":"59","author":"M Sakamoto","year":"2009","unstructured":"Sakamoto M, et al. Butyricimonas synergistica gen. nov., sp. nov. And Butyricimonas Virosa sp. nov., Butyric acid-producing bacteria in the family \u2018Porphyromonadaceae\u2019 isolated from rat faeces. Int J Syst Evol Microbiol. 2009;59(Pt 7):1748\u201353.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"2","key":"4749_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ajcn\/77.2.411","volume":"77","author":"KD Setchell","year":"2003","unstructured":"Setchell KD, et al. Comparing the pharmacokinetics of Daidzein and genistein with the use of 13\u00a0C-labeled tracers in premenopausal women. Am J Clin Nutr. 2003;77(2):411\u20139.","journal-title":"Am J Clin Nutr"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04749-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04749-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04749-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:08:47Z","timestamp":1781629727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04749-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4749"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04749-7","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Hirosaki University Graduate School of Medicine Ethics Committee (Approval code; 2016-028-1, 2017-030, 2018-063, 2019-009). All procedures were performed in accordance with the ethical standards of the relevant committees on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and its later amendments. Informed consent was obtained from all patients included the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}